September 7, 2017 / 11:24 AM / 3 months ago

BRIEF-CASI provides pipeline development update

Sept 7 (Reuters) - CASI Pharmaceuticals Inc

* CASI provides pipeline development update

* CASI Pharmaceuticals Inc- CFDA has granted priority review for co’s import drug registration clinical trial application for EVOMELA for injection Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below